Check-Cap Stock-Based Compensation 2014-2024 | CHEK

Check-Cap stock-based compensation from 2014 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors

Check-Cap Stock-Based Compensation 2014-2024 | CHEK

Check-Cap stock-based compensation from 2014 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$180.2B
Intuitive Surgical (ISRG)$179.4B
Edwards Lifesciences (EW)$47.6B
IDEXX Laboratories (IDXX)$46B
Alcon (ALC)$44B
DexCom (DXCM)$34.9B
IQVIA Holdings (IQV)$32.6B
Mettler-Toledo (MTD)$26.3B
STERIS (STE)$22.6B
Waters (WAT)$17.8B
SONOVA HOLDING (SONVY)$16.4B
Hologic (HOLX)$14.5B
Sysmex ADR (SSMXY)$10.4B
Penumbra (PEN)$9.8B
Masimo (MASI)$8.5B
Globus Medical (GMED)$7.2B
Glaukos (GKOS)$5.4B
Teleflex (TFX)$5B
Integer Holdings (ITGR)$3.8B
TransMedics (TMDX)$3.6B
PROCEPT BioRobotics (PRCT)$2.8B
LivaNova (LIVN)$2.4B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.9B
Veracyte (VCYT)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Tandem Diabetes Care (TNDM)$1.1B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B